Invivo therapeutics announces publication in peer-reviewed journal of neurosurgery: spine

Cambridge, mass.--(business wire)--invivo therapeutics holdings corp. (nasdaq: nviv) today announced the recent publication of a peer-reviewed manuscript in the journal of neurosurgery: spine describing the previously presented complete six-month primary endpoint results from the company's single-arm inspire 1.0 study (invivo study of probable benefit of the neuro-spinal scaffold™ for safety and neurologic recovery in subjects with complete thoracic ais a spinal cord injury), titled “a study of
NVIV Ratings Summary
NVIV Quant Ranking